Treatment of patients with myelodysplastic syndrome with iron overload oral chelator deferasirox

Abstract

In patients with MDS distinguish between high-and low-risk MDS using the International Prognostic Scoring System IPSS. The main problem is more or less symptomatic anemia.

Keywords

• myelodysplastic syndrome
• iron overload
• chelator deferasirox